CURE3d
COCOON Trial Regimen Reduces Dermatologic Side Effects in Mutated Lung Cancer
The COCOON trial regimen reduced dermatologic side effects in patients with EGFR-mutant non-small cell lung cancer, phase 2 ...
Medscape2d
Skin Care Regimen Cuts Toxicities of Combination NSCLC Therapy
Standard-of-care dermatologic management included general skin prophylaxis per local practice ... “Demonstrating early success, the COCOON trial met its primary endpoint at the first interim ...
PharmExec3d
Phase II Trial Shows Combination of Rybrevant Plus Lazcluze Significantly Reduces Moderate-to-Severe Skin, Nail Reactions in EGFR-Mutated NSCLC
Results from the COCOON study showed that Rybrevant plus Lacluze reduced grade 2 or higher dermatologic events by 50% ...